Cellosaurus cell line 1383D2-B2M-KO #2 (CVCL

Cross-references
Cell line name	1383D2-B2M-KO #2
Accession	CVCL_C1FL
Resource Identification Initiative	To cite this cell line use: 1383D2-B2M-KO #2 (RRID:CVCL_C1FL)
Comments	Population: Asian. Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy	Parent: CVCL_UP38 (1383D2)
Sex of cell	Male
Age at sampling	36Y
Category	Induced pluripotent stem cell
Publications	PubMed=30853558; DOI=10.1016/j.stem.2019.02.005 Huai-Geng Xu, Bo Wang, Miyuki Ono, Akihiro Kagita, Kaho Fujii, Noriko Sasakawa, Tatsuki Ueda, Peter Gee, Misato Nishikawa, Masaki Nomura, Fumiyo Kitaoka ...Show all 16 authors... , Tomoko Takahashi, Keisuke Okita, Yoshinori Yoshida, Shin Kaneko, Akitsu Hotta; Show fewer authors Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24:566-578.e7(2019) Patent=US20200407693 Akitsu Hotta, Huai-Geng Xu, Shin Kaneko, Bo Wang; Method for producing low-antigenic cell. Patent number US20200407693, 31-Dec-2020
Encyclopedic resources	Wikidata; Q114310348
Entry history
Entry creation	22-Sep-2022
Last entry update	19-Dec-2024
Version number	5